China 1,4-dihydropyridine-2-carboxylic Factory

As a way to present you with ease and enlarge our enterprise, we also have inspectors in QC Workforce and assure you our greatest support and solution for 1,4-dihydropyridine-2-carboxylic,CAS NO 1985607-66-6,1985607-66-6,Baloxavir intermediate,Baloxavir advance intermediate, Our main objectives are to deliver our clients worldwide with good quality, competitive cost, happy delivery and superb providers.
1,4-dihydropyridine-2-carboxylic, Faced with the vitality of the global wave of economic integration, we are confident with our high-quality products and sincerely service to all our customers and wish we can cooperate with you to create a brilliant future.

Hot Products

  • CeftazidiMe

    CeftazidiMe

    Product Name:CeftazidiMe
    Molecular Formula:C22H22N6O7S2
    Molecular Weight;546.57
    CAS Registry Number;72558-82-8
  • Bortezomib

    Bortezomib

    Product Name:Bortezomib
    Molecular Formula:C19H25BN4O4
    Molecular Weight;384.24
    CAS Registry Number;179324-69-7
  • Oteseconazole

    Oteseconazole

    Product Name:Oteseconazole
    Molecular Formula:C23H16F7N5O2
    Molecular Weight;527.4
    CAS Registry Number;1340593-59-0
  • Sorafenib tosylate

    Sorafenib tosylate

    Product Name:Sorafenib tosylate
    Molecular Formula:C28H24ClF3N4O6S
    Molecular Weight;637.03
    CAS Registry Number;475207-59-1
  • 3-(2-Chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one

    3-(2-Chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one

    Product Name:3-(2-Chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
    Molecular Formula:C11H15ClN2O
    Molecular Weight:226.7
    CAS Registry Number:63234-80-0
  • Rosiptor

    Rosiptor

    Product Name:Rosiptor
    Molecular Formula:C20H35NO2
    Molecular Weight;321.5
    CAS Registry Number;782487-28-9

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept